TF and triple-negative breast carcinoma: This research was conducted in a fashion similar to Goswami et al. [23] who reported on Se-Transferrin against leukemia cell lines and Khandelwal et al. for their comparison of Se-Herceptin®, and Avastin® against Triple Negative Breast Cancer (TNBC) cell lines [24].